Table of Contents
1 Introduction (Page No. – 11)
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 15)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 25)
4 Premium Insights (Page No. – 28)
4.1 Wearable Injectors Market: Overview
4.2 Global Market, By Type, 2018 vs 2023
4.3 Geographic Analysis: Global Market, By Therapy
4.4 Geographic Snapshot: Global Market
5 Wearable Injectors Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Chronic Diseases
5.2.1.2 Favorable Reimbursement Scenario in Major Markets
5.2.1.3 Technological Advancements and Design Development
5.2.2 Restraints
5.2.2.1 Preference for Alternative Drug Delivery Modes
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Biologics and MABS
5.2.4 Challenges
5.2.4.1 Unfavorable Reimbursement Structure in Developing Countries
6 By Type (Page No. – 35)
6.1 Introduction
6.2 On-Body Injectors
6.3 Off-Body Injectors
7 By Therapy (Page No. – 39)
7.1 Introduction
7.2 Immuno-Oncology
7.3 Diabetes
7.4 Cardiovascular Diseases
7.5 Other Therapies
8 By Region (Page No. – 46)
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 RoAPAC
8.5 Rest of the World
9 Competitive Landscape (Page No. – 74)
9.1 Overview
9.2 Market Share Analysis
9.3 Market Share Analysis, By Therapy
9.3.1 Immuno-Oncology
9.3.2 Amgen
9.3.3 Diabetes
9.3.4 Medtronic
9.3.5 Insulet Corporation
9.3.6 Cardiovascular Diseases
9.3.7 United Therapeutics
9.4 Competitive Scenario
9.4.1 Product Launches and Approvals
9.4.2 Expansions
9.4.3 Agreements, Collaborations, and Partnerships
10 Company Profiles (Page No. – 79)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
10.1 Amgen
10.2 Medtronic PLC
10.3 Insulet Corporation
10.4 Ypsomed
10.5 Becton, Dickinson and Company
10.6 Tandem Diabetes Care, Inc.
10.7 United Therapeutics Corporation
10.8 Valeritas, Inc.
10.9 Enable Injections
10.10 Steadymed Therapeutics
10.11 Sensile Medical (A Part of Gerresheimer)
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
11 Appendix (Page No. – 98)
11.1 Discussion Guide
11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.3 Available Customizations
11.4 Related Reports
11.5 Author Details
Table 1 Wearable Injectors (WI) Market, By Type, 2016–2023 (USD Billion)
Table 2 On-Body WI Market, By Country, 2016–2023 (USD Million)
Table 3 Off-Body WI Market, By Country, 2016–2023 (USD Million)
Table 4 Global Market, By Therapy, 2016–2023 (USD Billion)
Table 5 Global Market for Immuno-Oncology, By Country, 2016–2023 (USD Million)
Table 6 Insulin Devices Available for Diabetic Patients
Table 7 Global Market for Diabetes, By Country, 2016–2023 (USD Million)
Table 8 Global Market for Cardiovascular Diseases, By Country, 2016–2023 (USD Million)
Table 9 Global Market for Other Therapies, By Country, 2016–2023 (USD Million)
Table 10 Global Market, By Region, 2016-2023 (USD Million)
Table 11 North America: Wearable Injectors Market, By Country, 2016-2023 (USD Million)
Table 12 North America: Market, By Therapy, 2016-2023 (USD Million)
Table 13 North America: Market, By Type, 2016-2023 (USD Million)
Table 14 US: Market, By Therapy, 2016-2023 (USD Million)
Table 15 US: Market, By Type, 2016-2023 (USD Million)
Table 16 Canada: Market, By Therapy, 2016-2023 (USD Million)
Table 17 Canada: Market, By Type, 2016-2023 (USD Million)
Table 18 Recent Developments in the Wearable Injectors Market in Europe, 2015–2018
Table 19 Europe: Market, By Country, 2016-2023 (USD Million)
Table 20 Europe: Market, By Therapy, 2016-2023 (USD Million)
Table 21 Europe: Market, By Type, 2016-2023 (USD Million)
Table 22 Germany: Market, By Therapy, 2016-2023 (USD Million)
Table 23 Germany: Market, By Type, 2016-2023 (USD Million)
Table 24 UK: Market, By Therapy, 2016-2023 (USD Million)
Table 25 UK: Market, By Type, 2016-2023 (USD Million)
Table 26 France: Wearable Injectors Market, By Therapy, 2016-2023 (USD Million)
Table 27 France: Market, By Type, 2016-2023 (USD Million)
Table 28 RoE: Market, By Therapy, 2016-2023 (USD Million)
Table 29 RoE: Market, By Type, 2016-2023 (USD Million)
Table 30 Asia Pacific: Market, By Country, 2016-2023 (USD Million)
Table 31 Asia Pacific: Market, By Therapy, 2016-2023 (USD Million)
Table 32 Asia Pacific: Market, By Type, 2016-2023 (USD Million)
Table 33 Japan: Wearable Injectors Market, By Therapy, 2016-2023 (USD Million)
Table 34 Japan: Market, By Type, 2016-2023 (USD Million)
Table 35 China: Market, By Therapy, 2016-2023 (USD Million)
Table 36 China: Market, By Type, 2016-2023 (USD Million)
Table 37 India: Market, By Therapy, 2016-2023 (USD Million)
Table 38 India: Market, By Type, 2016-2023 (USD Million)
Table 39 RoAPAC: Market, By Therapy, 2016-2023 (USD Million)
Table 40 RoAPAC: Wearable Injectors Market, By Type, 2016-2023 (USD Million)
Table 41 Conferences in Africa, Brazil, and the Middle East (2016–2018)
Table 42 RoW: Market, By Therapy, 2016-2023 (USD Million)
Table 43 RoW: Market, By Type, 2016-2023 (USD Million)
Table 44 Product Launches and Approvals
Table 45 Expansions
Table 46 Agreements, Collaborations, and Partnerships
List of Figures (30 Figures)
Figure 1 Wearable Injectors Market: Research Methodology Steps
Figure 2 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Research Design
Figure 6 Data Triangulation Methodology
Figure 7 Immuno-Oncology Therapy Segment to Dominate the Wearable Injectors Market in 2018
Figure 8 On-Body Injectors to Account for the Largest Share of the Global Market in 2018
Figure 9 North America to Witness the Highest Market Growth During the Forecast Period
Figure 10 Growing Prevalence of Chronic Diseases is Driving Market Growth
Figure 11 On-Body Injectors Segment to Dominate the Market in 2018
Figure 12 Immuno-Oncology Segment to Command the Largest Share of the Market in 2018
Figure 13 North America to Witness the Highest Growth Rate During the Forecast Period
Figure 14 Wearable Injectors Market: Drivers, Restraints, Opportunities, & Challenges
Figure 15 Global Market, By Type, 2018 vs 2023 (USD Billion)
Figure 16 Wearable Injectors Market, By Therapy, 2018 vs 2023 (USD Billion)
Figure 17 North America to Command the Largest Market Share in 2018
Figure 18 North America: Market Snapshot
Figure 19 Europe: Market Snapshot
Figure 20 Asia Pacific: Market Snapshot
Figure 21 RoW: Market Snapshot
Figure 22 Strategies Adopted By Market Players (2014–2018)
Figure 23 Amgen: Company Snapshot (2017)
Figure 24 Medtronic PLC: Company Snapshot (2017)
Figure 25 Insulet Corporation: Company Snapshot (2017)
Figure 26 Ypsomed: Company Snapshot (2017)
Figure 27 BD: Company Snapshot (2017)
Figure 28 Tandem Diabetes Care: Company Snapshot (2017)
Figure 29 United Therapeutics Corporation: Company Snapshot (2017)
Figure 30 Valeritas: Company Snapshot (2017)